News & Press

DPU welcomes IMPACT-OC partners to Krems for Project Kick-off

Nov 12, 2026

DPU welcomes IMPACT-OC partners to Krems for Project Kick-off

International partners met at DPU on 10 November to launch their joint research on artificial intelligence and ovarian cancer.

International Research Project Launched

On 10 November 2026, Danube Private University (DPU) hosted the kick-off meeting of the EU-funded IMPACT-OC project in Krems. Partners from five European countries joined in person and online. The four-year project started on 1 October 2026 and receives nearly four million euros in EU funding.

IMPACT-OC (Interpretable Multimodal Predictive Agents and Digital Twins for Ovarian Cancer) aims to develop transparent AI methods combining medical imaging, tissue samples, genetic information and clinical data. Digital patient models will help researchers explore possible disease and treatment trajectories.

DPU Coordinates the Consortium

DPU coordinates the international consortium of ten organisations and acts as the coordinating sponsor of the research studies. The university's Medical Image Analysis & Artificial Intelligence (MIAAI) research group, based at the Technology and Research Centre in Wiener Neustadt, contributes expertise in medical image analysis, radiomics and deep learning.

The project is coordinated by Univ.-Prof. Priv.-Doz. Dr. Ramona Woitek, PhD, Head of the MIAAI research group. She highlights the importance of international collaboration and the involvement of patient organisations. Ioannis Lazarou, MSc, PhD, DPU's Coordinator for EU Research Projects, also describes the project as an important milestone for the university.

AI and Digital Twins in Research

IMPACT-OC focuses on three main areas: supporting treatment decisions in advanced ovarian cancer, identifying potential hereditary cancer risks, and improving the assessment of abnormalities in the ovarian region.

Another key element is the development of digital twins to model possible disease and treatment trajectories. The methods will initially be tested exclusively in research settings using de-identified data. During pilot studies, the AI will operate in “shadow mode”: its results will not be shown to treating physicians and will not influence patient care.

Patient organisations are involved from the outset to ensure that their perspectives and concerns are considered in the development of the technologies.

DPU Director Robert Wagner, MA, describes IMPACT-OC as an important milestone for the university's research development, demonstrating how medicine, artificial intelligence and international collaboration can advance research for the benefit of patients.

Project duration: 1 October 2026 – 30 September 2030

IMPACT-OC – Grant Agreement No. 101306266

Funded by the European Union.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.